Signify Premium Insight: HeartFlow’s Death-Defying Claims

The European Society of Cardiology Congress meeting in Amsterdam enjoyed the presentation of the two-year results of the FISH&CHIPS study, a real world, multi-centre, retrospective clinical study of 90,553 National Health Service (NHS) patients.

The study assessed the impact of the use of HeartFlow’s FFR-CT evaluation and diagnosis of coronary artery disease, a solution that, for some patients, can avoid invasive catheterisation processes which would otherwise have been used.

The two-year outcomes of the study were very positive, with key outcomes including:

• A 14% relative reduction in cardiovascular mortality and 8% relative reduction in all-cause mortality.
• An increase in cath lab efficiency driven by a 5% relative reduction in invasive cardiac angiography and an 8% relative increase in Percutaneous Coronary Intervention.
• A 14% relative reduction in additional non-invasive heart testing.